Developmental strategies for evasion of Arf tumor suppression

Cell Cycle. 2010 Jan 1;9(1):14-5. doi: 10.4161/cc.9.1.10390. Epub 2010 Jan 21.

Authors

Emmanuel J Volanakis, Charles J Sherr

PMID: 20009580
DOI: 10.4161/cc.9.1.10390

No abstract available

Publication types

Editorial

MeSH terms

Animals
CD4-Positive T-Lymphocytes / metabolism
CD8-Positive T-Lymphocytes / metabolism
Cyclin-Dependent Kinase Inhibitor p16 / genetics
Cyclin-Dependent Kinase Inhibitor p16 / physiology*
Epigenesis, Genetic / genetics
Epigenesis, Genetic / physiology
Hematopoietic Stem Cells / metabolism
Hematopoietic Stem Cells / physiology
Humans
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / immunology
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
Receptor, Notch1 / genetics
Receptor, Notch1 / metabolism

Substances

Cyclin-Dependent Kinase Inhibitor p16
Receptor, Notch1